Stifel 2025 Healthcare Conference November 12, 2025 4:40 PM ESTCompany ParticipantsRachel McMinn - Founder, Executive Chair ...
Q3 2025 Earnings Call Transcript November 4, 2025 Taysha Gene Therapies, Inc. misses on earnings expectations. Reported EPS ...
Type 1 diabetes is an autoimmune disease in which the insulin-producing β cells in the pancreatic islets of Langerhans are ...
Unpredictable communication and a lack of transparency are eroding the industry’s and the public’s trust. The FDA, experts ...
Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...
After Intellia Therapeutics paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the ...
Intellia Therapeutics downgraded to Sell amid safety, regulatory setbacks and weak market prospects. Click here to read an ...
Excerpts from recent editorials in the United States and abroad: ___ Nov. 9 The Washington Post says TrumpRx isn't the best way to lower prices In a landmark deal announced Thursday, President Donald ...
An analysis has found that the popularization of advanced regenerative medicine, made possible by a legal amendment in February, is highly likely to ...
This insightful review explores key areas of cancer genetic research, focusing on genes that may benefit from single-chromosome sequencing ...
Traditional medications are synthesized through chemical reactions, whereas biologics are derived from and reproduced, at ...
Industry leaders say uncertainty in funding, clinical development and manufacturing is driving companies to embrace digital transformation, streamlined operations and strategic partnerships to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback